BlackRock’s Ultralife ULBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $954K | Buy |
146,273
+174
| +0.1% | +$1.08K | ﹤0.01% | 4363 |
|
|
2025
Q4 | $836K | Buy |
146,099
+273
| +0.2% | +$1.68K | ﹤0.01% | 4355 |
|
|
2025
Q3 | $995K | Buy |
145,826
+478
| +0.3% | +$3.62K | ﹤0.01% | 4284 |
|
|
2025
Q2 | $1.31M | Sell |
145,348
-493,471
| -77% | -$2.93M | ﹤0.01% | 4171 |
|
|
2025
Q1 | $3.44M | Sell |
638,819
-16,817
| -3% | -$114K | ﹤0.01% | 3790 |
|
|
2024
Q4 | $4.88M | Buy |
655,636
+8,145
| +1% | +$67K | ﹤0.01% | 3743 |
|
|
2024
Q3 | $5.85M | Buy |
647,491
+37,455
| +6% | +$386K | ﹤0.01% | 3639 |
|
|
2024
Q2 | $6.48M | Buy |
610,036
+461,760
| +311% | +$4.92M | ﹤0.01% | 3588 |
|
|
2024
Q1 | $1.31M | Buy |
148,276
+642
| +0.4% | +$5.22K | ﹤0.01% | 4119 |
|
|
2023
Q4 | $1.01M | Buy |
147,634
+5,405
| +4% | +$44.4K | ﹤0.01% | 4252 |
|
|
2023
Q3 | $1.39M | Sell |
142,229
-3,001
| -2% | -$24K | ﹤0.01% | 4128 |
|
|
2023
Q2 | $703K | Buy |
145,230
+2,873
| +2% | +$12.5K | ﹤0.01% | 4387 |
|
|
2023
Q1 | $572K | Sell |
142,357
-8,720
| -6% | -$35K | ﹤0.01% | 4498 |
|
|
2022
Q4 | $583K | Buy |
151,077
+112
| +0.1% | +$517 | ﹤0.01% | 4571 |
|
|
2022
Q3 | $726K | Sell |
150,965
-1,603
| -1% | -$7.58K | ﹤0.01% | 4598 |
|
|
2022
Q2 | $694K | Buy |
152,568
+449
| +0.3% | +$2.21K | ﹤0.01% | 4666 |
|
|
2022
Q1 | $817K | Sell |
152,119
-1,226
| -0.8% | -$6.56K | ﹤0.01% | 4729 |
|
|
2021
Q4 | $926K | Buy |
153,345
+9,303
| +6% | +$57.1K | ﹤0.01% | 4693 |
|
|
2021
Q3 | $1.03M | Sell |
144,042
-3,578
| -2% | -$28.8K | ﹤0.01% | 4544 |
|
|
2021
Q2 | $1.24M | Sell |
147,620
-399,398
| -73% | -$3.44M | ﹤0.01% | 4447 |
|
|
2021
Q1 | $4.53M | Buy |
547,018
+7,335
| +1% | +$52K | ﹤0.01% | 3984 |
|
|
2020
Q4 | $3.49M | Buy |
539,683
+72,360
| +15% | +$457K | ﹤0.01% | 3844 |
|
|
2020
Q3 | $2.76M | Buy |
467,323
+5,717
| +1% | +$37.6K | ﹤0.01% | 3806 |
|
|
2020
Q2 | $3.24M | Buy |
461,606
+294,092
| +176% | +$2.15M | ﹤0.01% | 3686 |
|
|
2020
Q1 | $872K | Sell |
167,514
-289
| -0.2% | -$1.98K | ﹤0.01% | 3914 |
|
|
2019
Q4 | $1.24M | Buy |
167,803
+738
| +0.4% | +$6.12K | ﹤0.01% | 3937 |
|
|
2019
Q3 | $1.45M | Sell |
167,065
-1,072
| -0.6% | -$9.17K | ﹤0.01% | 3853 |
|
|
2019
Q2 | $1.34M | Buy |
168,137
+136,995
| +440% | +$1.25M | ﹤0.01% | 3918 |
|
|
2019
Q1 | $320K | Sell |
31,142
-3,471
| -10% | -$31.1K | ﹤0.01% | 4170 |
|
|
2018
Q4 | $234K | Buy |
34,613
+234
| +0.7% | +$1.7K | ﹤0.01% | 4198 |
|
|
2018
Q3 | $280K | Buy |
34,379
+1,354
| +4% | +$12.7K | ﹤0.01% | 4254 |
|
|
2018
Q2 | $317K | Buy |
33,025
+2,857
| +9% | +$27.4K | ﹤0.01% | 4213 |
|
|
2018
Q1 | $302K | Sell |
30,168
-88,003
| -74% | -$681K | ﹤0.01% | 4131 |
|
|
2017
Q4 | $774K | Buy |
118,171
+1,444
| +1% | +$9.68K | ﹤0.01% | 3967 |
|
|
2017
Q3 | $789K | Sell |
116,727
-1,262
| -1% | -$8.6K | ﹤0.01% | 3974 |
|
|
2017
Q2 | $850K | Buy |
117,989
+5,559
| +5% | +$34K | ﹤0.01% | 3884 |
|
|
2017
Q1 | $613K | Buy |
+112,430
| New | +$612K | ﹤0.01% | 3914 |
|
|
2013
Q3 | – | Sell |
-3,543
| Closed | -$13K | – | 3112 |
|
|
2013
Q2 | $13K | Buy |
+3,543
| New | +$13.8K | ﹤0.01% | 2514 |
|
Other funds holding ULBI
VWA
VCM
THC
RC
BlackRock's ULBI Position: Q1 2026 in Review
BlackRock increased its Ultralife (ULBI) stake by 0.12% in Q1 2026, buying an estimated $1.08K and bringing the position to 146,273 shares worth $954K. The position accounts for ﹤0.01% of the portfolio, ranked #4363.
BlackRock first reported a position in ULBI in Q2 2013 and has held it in 38 quarters since. The position peaked at $6.48M in Q2 2024. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.
- BlackRock held 146,273 shares of Ultralife worth $954K as of Q1 2026.
- BlackRock bought 174 Ultralife shares in Q1 2026, an estimated $1.08K.
- Ultralife made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4363 holding.
- BlackRock first reported a position in Ultralife in Q2 2013 and has held it in 38 quarters since.
- BlackRock's Ultralife position peaked at $6.48M in Q2 2024.
- 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.